Caixin
Aug 26, 2022 08:00 AM

Guanhao Biotech Co.,Ltd. Posted 247.2 Million Yuan Net Loss in First Half of 2022

Guanhao Biotech Co.,Ltd. (冠昊生物科技股份有限公司) (300238.SZ) reported a net loss of 247.2 million yuan in the first half of 2022, reversing a net profit of 33 million yuan for the same period in the previous year.

Meanwhile, the company posted 202.9 million yuan in revenue, down 22.7% year-on-year.

At the end of the reporting period, it had 794.7 million yuan in total assets and 289.8 million yuan in total liabilities, with a liability-to-asset ratio of 36.5%.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Business Uncovered Podcast: Brazil’s ‘Very Chinese Moment’
00:00
00:00/00:00